Skip to main content
. 2023 Mar 16;55(4):607–618. doi: 10.1038/s41588-023-01321-1

Fig. 6. Added value of the four-factor molecular classification in understanding intertumor heterogeneity in three example patients.

Fig. 6

a, Patients MESO_019, MESO_079 and MESO_085 had nearly identical clinical characteristics. b, The three patients had vastly different profiles based on our four-factor morphomolecular classification: different WGD status (left), opposite positions on the Pareto front (middle) and variable levels of CpG island methylation (right).

Source data